Investors

|

Portal
Order
Home / Research / Publications / Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis

Publications

Back

Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis

– Caris Life Sciences

Poster

Background

A great need exists for new therapeutic approaches for patients with pancreatic cancer

Download Publication

Discover
More

  • Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profiling

    – Caris Life Sciences

    Manuscript

    Abstract Trastuzumab deruxtecan (T-DXd) is an antibody-drug conjugate successfully used to treat HER2-low and HER2-positive metastatic breast cancer, but resistance consistently develops. Using multivariate Cox… […]

  • Comprehensive Characterization of PTEN loss by IHC and PTEN alteration by NGS in Metastatic HR-Positive, HER2-Negative Breast Cancer: An Exploratory Analysis of Biomarker Concordance and Co-Occurrence

    – Caris Life Sciences

    Poster

    Key Findings […]
Learn More

Ready to Get Started on the Journey?